Diseases, Conditions, Syndromes

Successful TB vaccine moves forward after phase 2 trial

Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth's Geisel School of Medicine and published in the journal Vaccine. The three-year trial was conducted ...

Diseases, Conditions, Syndromes

Virus could set back tuberculosis fight by several years

The fight against tuberculosis could be set back by more than five years due to the coronavirus pandemic, risking an additional 1.4 million TB deaths and 6.3 million infections by 2025, a new report says.

Diseases, Conditions, Syndromes

Recent advances in addressing tuberculosis give hope for future

In September 2018, the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the ...

page 3 from 7